Skip Navigation

European Heart Journal 1999 20(9):645-652; doi:10.1053/euhj.1998.1339
Copyright © 1999 by the European Society of Cardiology.
This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Sätre, H.
Right arrow Articles by Wallentin, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sätre, H.
Right arrow Articles by Wallentin, L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Reduction of myocardial damage by prolonged treatment with subcutaneous low molecular weight heparin in unstable coronary artery disease

H. Sätrea, L. Holmvangb,f1, G.S. Wagnerc, B. Lindahld and L. Wallentind

a Department of Cardiology, Falun Hospital, Falun, Sweden
b The Heart Center, Rigshospitalet, Copenhagen, Denmark
c Duke University Medical Center, Division of Cardiology, Durham, North Carolina, U.S.A.
d Department of Cardiology, Uppsala University Hospital, Uppsala, Sweden

revised September 28, 1998; accepted September 30, 1998

Abstract

Aims

Several studies have proved heparin useful in treating patients with unstable coronary artery disease. The present study investigates whether Selvester QRS scoring for estimation of myocardial infarct size increases the incidence of detection of acute myocardial infarction during follow-up in a trial of patients with unstable angina/non-Q wave myocardial infarction treated with low molecular weight heparin or placebo. Finally it will be discussed how the QRS score, used for end-point identification, impacts on the power calculation in clinical trials.

Methods and Results

Electrocardiographic data on 1276 patients (644 in the placebo group, 632 in the low molecular weight heparin treatment group) were available. All ECGs were scored according to the Selvester QRS scoring method. At 40 days, more patients in the placebo than in the heparin group had achieved a threshold level of QRS score (25·9% vs 21·1%,P=0·05). Myocardial infarction, diagnosed as per the classic Q wave criteria, occurred in 3·7% of patients in the placebo group and in 0·9% in the low molecular weight heparin group at 6 days (P=0·002). At 40 days, the rates were 8·2% (placebo) and 5·7% (low molecular weight heparin,P=0·2). By combining the classic criteria with the Selvester method the myocardial infarction end-point rate in both groups was almost doubled (8·2% to 14·4% in the placebo group and 5·7% to 11·1% in the low molecular weight heparin group,P=0·07). The 216 patients with non-evaluable electrocardiograms did not differ from the 1276 patients as regards baseline characteristics; however, they had a significantly poorer prognosis, with a death/myocardial infarction rate of 20% at 40 days, compared with 8% among the patients with evaluable electrocardiograms (P<0·00001).

Conclusion

Long-term subcutaneous treatment with low molecular weight heparin decreases the number of subsequent myocardial infarctions—determined both conventionally and by an increase in QRS score—in patients with unstable coronary artery disease. Silent myocardial infarctions detected by QRS score, as well as clinical myocardial infarctions, could be used as end-points in clinical trials of ischaemic heart disease and thus lower the population needed for obtaining statistical power.

Key Words: Low molecular weight heparin • unstable angina • myocardial infarction • QRS score • statistical power

f1 Correspondence: Lene Holmvang, MD, The Heart Center 2141, Rigshospitalet, 2100 Copenhagen Ø, Denmark

References

  1. The FRISC study group. Low-molecular-weight heparin during instability in coronary artery disease, Fragmin during Instability in Coronary Artery Disease. Lancet. 1996;347:561–568[CrossRef][Web of Science][Medline]
  2. Wallentin L, Husted S, Kontny F, Swahn E. Long-term low-molecule-weight heparin (Fragmin) and/or early revascularization during instability in coronary artery disease (the FRISC II Study). Am J Cardiol. 1997;80:61E–63E[CrossRef][Medline]
  3. Kannel WB, Abbott RD. Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study. N Engl J Med. 1984;311:1144–1147[Abstract]
  4. Sigurdsson E, Thorgeirsson G, Sigvaldason H, Sigfusson N. Unrecognized myocardial infarction: epidemiology, clinical characteristics, and the prognostic role of angina pectoris. The Reykjavik Study. Ann Intern Med. 1995;122:96–102[Abstract/Free Full Text]
  5. Hindman NB, Schocken DD, Widmann M. Evaluation of a QRS scoring system for estimating myocardial infarct size. V. Specificity and method of application of the complete system. Am J Cardiol. 1985;55:1485–1490[CrossRef][Web of Science][Medline]
  6. Clemmensen P, Grande P, Saunamaki K, Wagner NB, Selvester RH, Wagner GS. Evolution of electrocardiographic and echocardiographic abnormalities during the first 4 years following first acute myocardial infarction. Eur Heart J. 1995;16:1063–1069[Abstract/Free Full Text]
  7. Hinohora T, Wagner NB, Cobb FR. An ischemic index from the electrocardiogram to select patients with low left ventricular ejection fraction for coronary artery bypass grafting. Am J Cardiol. 1988;61:288–291[CrossRef][Web of Science][Medline]
  8. Aldrich HR, Wagner NB, Boswick J. Use of initial ST-segment deviation for prediction of final electrocardiographic size of acute myocardial infarcts. Am J Cardiol. 1988;61:749–753[CrossRef][Web of Science][Medline]
  9. Shimada T, Tsuda N, Kamihata H. Quantification of infarct size by thallium-201 single-photon emission computed tomography using the unfolded map method. Comparison with QRS score and angiographic infarct size at 4 weeks after infarction. Clin Cardiol. 1994;17:184–190[Web of Science][Medline]
  10. Bergovec M, Prpic H, Mihatov S. The value of the QRS scoring system in assessing regional and global left ventricular ejection fraction early after myocardial infarction. Eur Heart J. 1993;14:1102–1109[Abstract/Free Full Text]
  11. Kornreich F, Selvester RH, Montague TJ, Rautaharju PM, Saetra HA, Ahmad J. Discriminant analysis of the standard 12-lead ECG for diagnosing non-Q wave myocardial infarction. J Electrocardiol. 1992;24 (Suppl):163–172
  12. Altman DG. Practical statistics for medical research. London: Chapman & Hall; 1995. p. 455–60
  13. The GUSTO IIb Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty substudy Investigators. N Engl J Med. 1997;336:1621–1628[Abstract/Free Full Text]
  14. The RISC Group. Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. Lancet. 1990;336:827–830[CrossRef][Web of Science][Medline]
  15. Theroux P, Ouimet H, McCans J. Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med. 1988;319:1105–1111[Abstract]
  16. Cohen M, Adams PC, Parry G. Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users. Primary end points analysis from the ATACS trial. Antithrombotic Therapy in Acute Coronary Syndromes Research Group. Circulation. 1994;89:81–88[Abstract/Free Full Text]
  17. Chaitman BR, Rosen AD, Williams DO. Myocardial infarction and cardiac mortality in the Bypass Angioplasty Revascularization Investigation (BARI) randomized trial. Circulation. 1997;96:2162–2170[Abstract/Free Full Text]
  18. Lancet. 1993;341:573–580[CrossRef][Web of Science][Medline]
  19. Ideker RE, Wagner GS, Ruth WK. Evaluation of a QRS scoring systems for estimating myocardial infarct size. II. Correlation with quantitative anatomic findings for anterior infarcts. Am J Cardiol. 1982;49:1604–1614[CrossRef][Web of Science][Medline]
  20. Roark SF, Ideker RE, Wagner GS. Evaluation of a QRS scoring system for estimating myocardial infarct size. III. Correlation with quantitative anatomic findings for inferior infarcts. Am J Cardiol. 1983;51:382–389[CrossRef][Web of Science][Medline]
  21. Hindman N, Grande P, Harrell Jr FE. Relation between electrocardiographic and enzymatic methods of estimating acute myocardial infarct size. Am J Cardiol. 1986;58:31–35[CrossRef][Web of Science][Medline]
  22. Jones MG, Anderson KM, Wilson PW, Kannel WB, Wagner NB, Wagner GS. Prognostic use of a QRS scoring system after hospital discharge for initial acute myocardial infarction in the Framingham cohort. Am J Cardiol. 1990;66:546–550[CrossRef][Web of Science][Medline]
  23. Bertolet BD, Hill JA. Unrecognized myocardial infarction. Cardiovasc Clin. 1989;20:173–182[Medline]
  24. Chaitman BR, Zhou SH, Tamesis B. Methodology of serial ECG classification using an adaptation of the NOVACODE for Q wave myocardial infarction in the Bypass Angioplasty Revascularization Investigation (BARI). J Electrocardiol. 1996;29:265–277[CrossRef][Web of Science][Medline]
  25. Pahlm US, Chaitman BR, Rautaharju PM, Selvester RH, Wagner GS. Comparison of the various electrocardiographic scoring codes for estimating anatomically documented sizes of single and multiple infarcts of the left ventricle. Am J Cardiol. 1998;81:809–815[CrossRef][Web of Science][Medline]
  26. Sevilla DC, Wagner NB, Anderson WD. Sensitivity of a set of myocardial infarction screening criteria in patients with anatomically documented single and multiple infarcts. Am J Cardiol. 1990;66:792–795[CrossRef][Web of Science][Medline]
  27. Califf RM, Abdelmeguid AE, Kuntz RE. Myonecrosis after revascularization procedures. J Am Coll Cardiol. 1998;31:241–251[Abstract/Free Full Text]
  28. Sadony V, Korber M, Albes G. Cardiac troponin I plasma levels for diagnosis and quantitation of perioperative myocardial damage in patients undergoing coronary artery bypass surgery. Eur J Cardiothorac Surg. 1998;13:57–65[Abstract/Free Full Text]
  29. Mair J, Larue C, Mair P, Balogh D, Calzolari C, Puschendorf B. Use of cardiac troponin I to diagnose perioperative myocardial infarction in coronary artery bypass grafting. Clin Chem. 1994;40:2066–2070[Abstract]
  30. Mair P, Mair J, Seibt I, Antretter H, Balogh D, Puschendorf B. Creatine kinase isoenzyme MB mass concentrations in patients undergoing aortocoronary bypass surgery. Clin Chim Acta. 1994;224:203–207[CrossRef][Web of Science][Medline]
  31. Kleiman NS. Primary and secondary safety endpoints from IMPACT II. Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis. Am J Cardiol. 1997;80:29B–33B[CrossRef][Medline]
  32. Schulman SP, Goldschmidt-Clermont PJ, Topol EJ. Effects of integrelin, a platelet glycoprotein IIb/IIIa receptor antagonist, in unstable angina. A randomized multicenter trial. Circulation. 1996;94:2083–2089[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Am Coll CardiolHome page
L. Holmvang, P. Clemmensen, B. Lindahl, B. Lagerqvist, P. Venge, G. Wagner, L. Wallentin, and P. Grande
Quantitative analysis of the admission electrocardiogram identifies patients with unstable coronary artery disease who benefit the most from early invasive treatment
J. Am. Coll. Cardiol., March 19, 2003; 41(6): 905 - 915.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Sätre, H.
Right arrow Articles by Wallentin, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sätre, H.
Right arrow Articles by Wallentin, L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?